Bruush Oral Care Stock EBITDA
| BRSHDelisted Stock | USD 0.0005 0.0001 16.67% |
Bruush Oral Care fundamentals help investors to digest information that contributes to Bruush Oral's financial success or failures. It also enables traders to predict the movement of Bruush Stock. The fundamental analysis module provides a way to measure Bruush Oral's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruush Oral stock.
Bruush |
Bruush Oral Care Company EBITDA Analysis
Bruush Oral's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Bruush Oral EBITDA | (10.49 M) |
Most of Bruush Oral's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bruush Oral Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Bruush Oral Care reported earnings before interest,tax, depreciation and amortization of (10.49 Million). This is 100.69% lower than that of the Personal Care Products sector and 100.44% lower than that of the Consumer Staples industry. The ebitda for all United States stocks is 100.27% higher than that of the company.
Bruush EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruush Oral's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruush Oral could also be used in its relative valuation, which is a method of valuing Bruush Oral by comparing valuation metrics of similar companies.Bruush Oral is currently under evaluation in ebitda category among its peers.
Bruush Fundamentals
| Return On Asset | -5.77 | |||
| Profit Margin | (2.57) % | |||
| Operating Margin | (5.29) % | |||
| Current Valuation | 2.51 M | |||
| Shares Outstanding | 100.97 M | |||
| Shares Owned By Insiders | 17.35 % | |||
| Shares Owned By Institutions | 12.96 % | |||
| Number Of Shares Shorted | 2.22 M | |||
| Price To Sales | 2.97 X | |||
| Revenue | 2.63 M | |||
| Gross Profit | 1.76 M | |||
| EBITDA | (10.49 M) | |||
| Net Income | (8.77 M) | |||
| Total Debt | 2.59 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (10.12) X | |||
| Cash Flow From Operations | (12.59 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (14.67) X | |||
| Number Of Employees | 11 | |||
| Market Capitalization | 8.68 M | |||
| Total Asset | 1.19 M | |||
| Retained Earnings | (26.39 M) | |||
| Working Capital | (1.41 M) | |||
| Net Asset | 1.19 M |
About Bruush Oral Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bruush Oral Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bruush Oral using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bruush Oral Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Bruush Stock
If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |